Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic

  • STATUS
    Recruiting
  • participants needed
    11000
  • sponsor
    University of California, San Francisco
Updated on 19 February 2024
covid-19
coronavirus infection

Summary

Prospective nationwide cohort study of pregnant women enrolled early in gestation and followed for Covid-19 exposure and infection, with follow up of obstetrical outcomes and infant development through the first year of life.

Description

ASPIRE is focused on the first trimester, a critical and vulnerable period when all of a baby's organ systems form and the placenta - the crucial connection between mom and baby - develops.

Currently, there are no data about the effects of COVID-19 infections in the first trimester. The study will provide critical information to:

  1. Guide the care of pregnant women
  2. Protect the safety of their babies and families
  3. Help those considering pregnancy in the future understand what it means to be pregnant in this new era

The investigators are recruiting 10,000 women from the start of pregnancy and will track COVID-19 exposures using frequent serology testing. The investigators will collect information during and after the pregnancy to try to determine the effects of COVID 19 for mom and baby.

Participants will be asked to do the following throughout pregnancy:

  • Submit frequent, quick (<1 minute each) symptom tracking reports using your mobile phone and/or computer.
  • Collect finger-stick blood samples from home at several points throughout your pregnancy.
  • Give permission to review medical records related to your pregnancy, delivery and baby's development.
  • Complete questionnaires online about your health during your pregnancy and after delivery of your baby.

Details
Condition Pregnancy Related, COVID, Corona Virus Infection, Early Pregnancy
Age 18-100 years
Clinical Study IdentifierNCT04388605
SponsorUniversity of California, San Francisco
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Over age 18
Participant is 4-10 weeks pregnant (gestation)

Exclusion Criteria

Male (biologically unable to achieve pregnancy)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.